Please login to the form below

Not currently logged in
Email:
Password:

Zevtera

This page shows the latest Zevtera news and features for those working in and with pharma, biotech and healthcare.

Basilea bags $72m upfront from Pfizer for antifungal license

Basilea bags $72m upfront from Pfizer for antifungal license

Basilea launched the antifungal in its first European markets last year - Austria, France, Germany, Italy and the UK - with combined sales of the antifungal and new antibiotic Zevtera (ceftobiprole) reaching ... Meanwhile, Basilea says it is still on the

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Basilea appoints commercial head Basilea appoints commercial head

    Ronald Scott, CEO of Basilea, commented that Veitch's “ extensive experience and in-depth knowledge of European pharmaceutical markets will be instrumental” as the company prepares to launch its antibiotic Zevtera

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics